International Journal of Clinical Oncology

简称 INT J CLIN ONCOL ·JAPAN ·出版周期 Bimonthly ·年均收录 154 篇

2.8

最新影响因子

3.70%

自引率

约25%

投稿难度

平均2月

审稿周期

期刊简介

International Journal of Clinical Oncology是一本专注于临床肿瘤学领域的学术期刊，ISSN号为1341-9625，由Springer Nature出版，出版地为日本，出版周期为月刊。该期刊的影响因子根据最新数据约为2.5，属于非开放获取（非OA）期刊，被SCI收录，中科院分区通常位于医学大类3区或4区。杂志的发文特点集中于临床肿瘤学相关研究，包括肿瘤诊断、治疗、预后及转化医学等领域，尤其关注亚洲人群的肿瘤研究。其质量较为稳定，审稿流程严谨，但影响因子相对中等，可能存在投稿竞争激烈或审稿周期较长的风险。总体而言，该期刊是临床肿瘤学领域具有一定影响力的国际期刊，适合发表高质量的临床肿瘤学研究成果。

影响因子趋势

近期发表

The surrogacy of disease-free survival for overall survival in locally advanced esophageal squamous cell carcinoma after neoadjuvant therapy 2026-09-07

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; sevabertinib for lung cancer, gemcitabine intravesical system and durvalumab for bladder cancer, azacitidine for leukemia, cemiplimab for skin cancer, and ropeginterferon alfa-2b for essential thrombocythemia 2026-09-06

A multicenter retrospective study on the clinical features of patients with human epidermal growth factor receptor 2-positive colorectal cancer (HGCSG2304) 2026-09-05

Gastrointestinal perforation associated with bevacizumab and palliative radiotherapy 2026-09-05

Prophylactic intravenous dexamethasone is associated with reduced cutaneous toxicity during first-line enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma: a multicenter prospective cohort study 2026-09-02

Cost-utility analysis of CAR-T therapy compared to standard of care in patients with relapsed/refractory diffuse large B-cell lymphoma in Colombia, 2025 2026-09-02

Adverse event-related discontinuation of maintenance Bacillus Calmette–Guérin therapy and oncological outcomes in non-muscle-invasive bladder cancer 2026-09-02

Regimen-stratified prognostic associations do not support treatment selection in metastatic renal cell carcinoma 2026-09-01

Histological heterogeneity of SLFN11 expression and its association with response to carboplatin plus paclitaxel therapy in salivary gland cancer 2026-09-01

Clinical outcomes of near-infrared photoimmunotherapy according to immune checkpoint inhibitor timing and treatment sequence: a multicenter retrospective study 2026-09-01